| AstraZeneca AG - Synagis 100 mg/1 ml, Injektionslösung |
| 65695 | | 02 | | Synagis 100 mg/1 ml | | Injektionslösung | | J06BD01 | | | | 05.07.2016 | | |
|
| Composition |
| palivizumabum 100 mg, histidinum, glycinum, aqua ad iniectabile q.s. ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Injection solution | | | | | | | | Active Agent | Dose |
|---|
| Palivizumab | 100 mg/ml |
| | BAG: Active Agent | Dose |
|---|
| Palivizumab | 100 mg |
| | | | Inactive agents |
|---|
| Glycin | | Histidine |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | | 927.62 | 1025.25 | A | SL | Yes |
|
